Cited 6 time in
Thalidomide induced nonspecific interstitial pneumonia in patient with relapsed multiple myeloma
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 강명희 | - |
| dc.contributor.author | 주지현 | - |
| dc.contributor.author | 김훈구 | - |
| dc.contributor.author | 강정훈 | - |
| dc.contributor.author | 전경녀 | - |
| dc.contributor.author | 김호철 | - |
| dc.contributor.author | 이경원 | - |
| dc.date.accessioned | 2025-04-08T06:00:11Z | - |
| dc.date.available | 2025-04-08T06:00:11Z | - |
| dc.date.issued | 2010-12 | - |
| dc.identifier.issn | 1226-3303 | - |
| dc.identifier.issn | 2005-6648 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/77725 | - |
| dc.description.abstract | A 63-year-old female diagnosed with relapsed multiple myeloma visited our hospital complaining of a persistent cough. Since July 2006, she had been taking 100 mg thalidomide daily and gradually developed shortness of breath and a persistent dry cough. A chest X-ray and computed tomography showed ground glass opacities in both lungs. An open lung biopsy of the right middle lobe under general anesthesia revealed chronic peribronchial inflammation, mild interstitial fibrosis, and intra-alveolar macrophage infiltration, with some hemosiderin features, compatible with non-specific interstitial pneumonia (NSIP). After discontinuing the thalidomide, the patient's symptoms did not deteriorate, although the radiographs did not improve. The patient is alive and well with regular outpatient follow-up without progression of the NSIP. | - |
| dc.format.extent | 3 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.title | Thalidomide induced nonspecific interstitial pneumonia in patient with relapsed multiple myeloma | - |
| dc.type | Article | - |
| dc.publisher.location | 대한민국 | - |
| dc.identifier.doi | 10.3904/kjim.2010.25.4.447 | - |
| dc.identifier.scopusid | 2-s2.0-78650993441 | - |
| dc.identifier.bibliographicCitation | Korean Journal of Internal Medicine, v.25, no.4, pp 447 - 449 | - |
| dc.citation.title | Korean Journal of Internal Medicine | - |
| dc.citation.volume | 25 | - |
| dc.citation.number | 4 | - |
| dc.citation.startPage | 447 | - |
| dc.citation.endPage | 449 | - |
| dc.type.docType | Article | - |
| dc.identifier.kciid | ART001498796 | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.subject.keywordAuthor | Interstitial | - |
| dc.subject.keywordAuthor | Lung diseases | - |
| dc.subject.keywordAuthor | Multiple myeloma | - |
| dc.subject.keywordAuthor | Thalidomide | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
